We are live on ! Find out more
CCM

Camber Capital Management Portfolio holdings

AUM $1.07B
1-Year Est. Return 8.19%
This Fund
S&P 500
This Quarter Est. Return
+9.78%
1 Year Est. Return
-8.19%
3 Year Est. Return
+26.6%
5 Year Est. Return
+54.57%
10 Year Est. Return
+164.72%
AUM
$972M
AUM Growth
–
Cap. Flow
+$939M
Cap. Flow %
96.54%
Top 10 Hldgs %
55.08%
Holding
43
New
43
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$59.9M
2
VTRS icon
Viatris
VTRS
+$53.8M
3
DGX icon
Quest Diagnostics
DGX
+$47.7M
4
VOLC
VOLCANO CORPORATION COM STK
VOLC
+$42.1M
5
HOLX
Hologic
HOLX
+$41.8M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 68.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BEAT
26
DELISTED
BioTelemetry, Inc.
BEAT
$10.6M 1.09%
+1,800,000
New +$6.06M
IDIX
27
DELISTED
IDENIX PHARMACEUTICALS INC
IDIX
$9.93M 1.02%
+2,750,000
New +$11.2M
GNMK
28
DELISTED
GenMark Diagnostics, Inc
GNMK
$9.82M 1.01%
+950,000
New +$13.1M
MGLN
29
DELISTED
Magellan Health Services, Inc.
MGLN
$9.81M 1.01%
+175,000
New +$9.16M
AMED
30
DELISTED
Amedisys
AMED
$9.3M 0.96%
+800,000
New +$9.16M
BSX icon
31
Boston Scientific
BSX
$68.4B
$9.27M 0.95%
+1,000,000
New +$8.48M
WCG
32
DELISTED
Wellcare Health Plans, Inc.
WCG
$9.22M 0.95%
+166,050
New +$9.28M
CCRN
33
DELISTED
Cross Country Healthcare
CCRN
$7.95M 0.82%
+1,540,000
New +$7.89M
TEVA icon
34
CALL
Teva Pharmaceuticals
TEVA
$40.4B
$7.84M 0.81%
+200,000
New +$7.79M
PLX icon
35
Protalix BioTherapeutics
PLX
$183M
$7.37M 0.76%
+150,000
New +$7.96M
RMTI icon
36
Rockwell Medical
RMTI
$27.2M
$7.22M 0.74%
+18,182
New +$7.71M
NVAX icon
37
Novavax
NVAX
$1.21B
$6.58M 0.68%
+160,550
New +$6.96M
ARWR icon
38
Arrowhead Research
ARWR
$12.1B
$6.23M 0.64%
+3,114,754
New +$6.37M
CELGZ
39
DELISTED
Celgene Corporation Contingent Value Rights
CELGZ
$4.88M 0.5%
+658,158
New +$4.77M
UAM
40
DELISTED
Universal American Corp
UAM
$4.63M 0.48%
+520,400
New +$4.72M
BLUE
41
DELISTED
bluebird bio
BLUE
$3.75M 0.39%
+11,580
New +$3.82M
NTUS
42
DELISTED
Natus Medical Inc
NTUS
$1.92M 0.2%
+140,928
New +$1.92M
ANTH
43
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$0 ﹤0.01%
+6,250
New +$233K
1
2

Similar funds

PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
NRD
Nebula Research & Development New York $1.17B AUM 15.19% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return
CCP
Camelot Capital Partners Laguna Beach, California $686M AUM 163.55% 1-Year Est. Return

Camber Capital Management's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Camber Capital Management, which disclosed 43 positions worth $972M. Its ten largest holdings account for 55% of the portfolio.

Its largest position is Elevance Health: 800,000 shares worth $65.5M.

By sector, the portfolio is most concentrated in Healthcare at 68% of assets.

  • Camber Capital Management's largest Q2 2013 buy was Elevance Health: 800,000 shares worth $65.5M.
  • Camber Capital Management's ten largest holdings make up 55% of its $972M portfolio in Q2 2013.
  • Camber Capital Management disclosed 43 positions in Q2 2013, its first 13F filing on record.

Based on Camber Capital Management's 13F filing for Q2 2013, filed 14 Aug 2013.